National Injury Control Program to save lives on Road : JP Nadda

accident

The Health Ministry will soon come out with a National Injury Control Program to provide health care and save lives of the lakhs of persons lost in accidents and to injury, announced health minister J P Nadda, while inaugurating the Third World Trauma Congress today.

“Road traffic injuries are among the three leading causes of death for people between 5 and 44 years of age,” Nadda pointed out. “Unless immediate and effective action is taken, road traffic injuries are predicted to become the 5th leading cause of death in the world, resulting in an estimated 24 lakh deaths each year,” he stated.

As per the latest statistic, in India 52 persons die every hour in various accidents.

Road injuries and deaths cause a colossal economic cost of up to 1.5% of the Gross National Product.

Nadda also said that to meet the challenges of trauma patients, we need to advance not only clinical practice and medical technology, but also the organization of our health care system and resources. He also urged for more convergence with Ministries such as Road Transport and Highways and other related stakeholders.

India is hosting the 3rd World Trauma Congress this year, the first and second one’s being held at ‘Rio de Jenario’ and ‘Frankfurt’.



Explosion at BPCL refinery in Kochi There has been an explosion at the oil refinery in Kochi, operated by Bharat Petroleum Corporation Ltd.The explosion happened at the electricity generation plant at the refinery. The power plant works on gas and was undergoing maintenance.The BPCL refinery is crucial to the supply of oil products such as petrol, diesel and LPG to Kerala as a whole. ...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS primarily develops, manufactures and markets products across various therapeuti...
Marksans Pharma gets USFDA approval for sale of anti-allergy drug Marksans Pharma Limited, an Indian pharmaceutical company, said it has received approval from the USFDA for the sale sale of its Loratadine Liquid Filled Capsules 10 mg in the US market.Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body and is used to treat sneezing, runny nose, watery eyes, hives, skin rash...
Aurobindo Pharma to launch HIV drug in Africa this year, gets tentative FDA nod Aurobindo Pharma Limited, a pharmaceutical manufacturing company based in Hyderabad, said it received a tentative approval for HIV drug Dolutegravir from US Food & Drug Administration.It is the first FDA approval of a generic version of Dolutegravir. Through a tie up with ViiV and the Clinton Health Access Initiative, Inc., the product is expected...
Glenmark Pharma discovers potential new anti-cancer drug Glenmark Pharmaceuticals said its overseas subsidiary has discovered a molecule that can potentially be used in targeting even difficult-to-treat lung cancer and colorectal cancer.The GBR 1372 molecule was discovered in the pharma company's Swiss laboratory and that the company plans to file an application with the US Food and Drug Administration to appr...
US FDA updates warning against widespread use of fluoroquinolones The US Food & Drug Administration issued a warning against casual usage of fluoroquinolone antibiotics, arguably the most widely used broad-spectrum antibiotic in India.USFDA advised that the side effects caused by the use of fluoroquinolone antibacterial drugs would outweigh the benefits for patients who have alternative treatment options.Patien...
Ayush ministry signs MOU with US Pharmacopeial to strengthen traditional medicine Ministry of Ayush, government of India signed a memorandum of understanding (MOU) with United States Pharmacopeial Convention for cooperation in the field of traditional medicine.The aim is to promote the safety, quality and integrity of traditional medicines and botanical dietary supplements, the government said.The U.S. Pharmacopeial Convention (US...
Lupin gets approval for new indigestion tablets in India Lupin Ltd announced today that it has received approval to launch Acotiamide 100 mg indigestion tablets in India from the Central Drugs Standard Control Organization.Acotiamide is a drug to be introduced into the Indian Pharmaceutical Market which could benefit millions of patients suffering from Dyspepsia or Indigestion, most common stomach complaints ...
Govt to speed up correction accident spot on national highways National Highways Authority of India (NHAI) will be delegated power to approve plans for rectifying road design in black spots in an effort to reduce accidents on national highways, minister of Road Transport & Highways and Shipping Nithin Gadkari said.Nithin Gadkari addressing a video conference of Regional Officers of the Ministry and NHAI highlighted ...
Glenmark announces discovery of novel cancer drug Glenmark Pharmaceuticals has announced the discovery of a new anti-cancer therapy by its Swiss subsidiary.The new drug, GBR 1302, will target breast cancer and ovarian cancer, and the company expects to start clinical studies this year.Unlike normal drugs, the new drug will work by making it easier for human body's defence mechanism, white blood ...